Akston Biosciences Doses First Participants in Phase II Clinical Trial for Shelf-Stable COVID-19 Booster
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
Akston Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Akston Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Akston Bioscience Today - Breaking & Trending Today
Akston Biosciences Corporation: Akston Biosciences Doses First Participants in Phase II Clinical Trial for Shelf-Stable COVID-19 Booster
Up to 600 volunteers will participate in an AKS-452 COVID booster study in the Netherlands to investigate boosting the immune response of those previously vaccinated with EMA-registered vaccines
Source: finanznachrichten.de
Akston Biosciences Doses First Volunteers in Phase II/III Clinical Trial of Low Cost, Shelf Stable COVID-19 Vaccine
BEVERLY, Mass. & BANGALORE, India--(BUSINESS WIRE)--Apr 7, 2022--
Source: kulr8.com